NDRG2 and breast cancer: Not only were their levels reduced in BC cells, but also the expression of NDRG2 was found to be negatively correlated with PD1 expression, suggesting that increasing NDRG2 expression could activate T-cell proliferation to counteract tumor invasion (Lee et al., 2021).